4//SEC Filing
Smith Stan 4
Accession 0001878313-25-000019
CIK 0001878313other
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:51 PM ET
Size
7.5 KB
Accession
0001878313-25-000019
Insider Transaction Report
Form 4
Smith Stan
Director
Transactions
- Purchase
Common Stock
2025-10-01$1.30/sh+19,230$24,999→ 1,324,289 total(indirect: See Footnote) - Purchase
Warrants
2025-10-01$1.57/sh+19,230$30,191→ 19,230 total(indirect: See footnote)Exercise: $1.57From: 2026-04-01Exp: 2028-10-01→ Common Stock (19,230 underlying)
Footnotes (4)
- [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on October 1, 2025
- [F2]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
- [F3]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options under the Issuer's 2021 Equity Incentive Plan on October 1, 2025. The options are exercisable beginning on the six-month anniversary of the issuance date and expire 3-years after the initial issuance date.
- [F4]These securities are beneficially owned by Mr. Smith through The Stan V. Smith Trust Dated 1993.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913199
Filing Metadata
- Form type
- 4
- Filed
- Oct 1, 8:00 PM ET
- Accepted
- Oct 2, 4:51 PM ET
- Size
- 7.5 KB